Submit Marketing Authorization Application (MAA) for Vicineum to the EMA
Deadline passed; outcome being checked
- Announced
- 11 Jan 2021
- Due
- 31 Mar 2022
- Status
- Checking
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“MAA submission”
What we found
The deadline has passed. We check for public evidence starting 30 days after the deadline, and repeat the check if nothing clear turns up.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- Deadline drift -349 days
- 2 versions
-
Version 1 · original · stated 11 Jan 2021
Deadline 31 Mar 2022 (“1Q 22”)
-
Version 2 · stated 16 Feb 2021
Deadline 16 Apr 2021 (“In the next one to two months”) · wording expected
“In the next one to two months, the Company expects to submit its Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for Vicineum”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory submission
- Indicative materiality
- High rules
- Action
- Submit
- Deliverable
- MAA submission
- Where
- Europe
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
Tell me what happens
This deadline has not been settled yet. We check 30 days after it passes. Get an email when we record the outcome.
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- OutcomeNot yet assessed. Nothing is judged before the deadline.
Are you Sesen Bio, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C485003-021727 · Corrections policy